FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041628293> ?p ?o ?g. }

• W3041628293 endingPage "147" @default.
• W3041628293 startingPage "140" @default.
• W3041628293 abstract "Given the ongoing problems of hypertension and endothelial dysfunction in the HIV population, the primary objective of the study was to assess the cardiovascular, endothelial function, and immune markers in response to rice bran arabinoxylan compound (RBAC) treatment in a sample of HIV+ adults on antiretroviral therapy (ART).A randomized, double-blind placebo-controlled trial of 6 months was used to execute the study.Forty-seven subjects were enrolled and randomly assigned to one of two study conditions (n=22 RBAC and n=25 placebo) for 6 months with assessments at baseline and 3 and 6 months. A multivariate repeated measures analysis of variance model was used to assess the differences between RBAC and placebo groups in cardiovascular (systolic blood pressure), endothelial function (skin blood flow in response to nitric oxide), and immune (CD4+ cell count) markers from baseline to 6 months.The effect of treatment (RBAC versus placebo) was significant (Wilks' λ=0.92, F[3, 102]=3.07, P=0.03). The effect of time was significant (Wilks' λ=0.10, F[2, 103]=474.6, P<0.001). The overall interaction between treatment and time was significant (Wilks' λ=0.92, F[2, 103]=4.58, P=0.01). Time contrasts showed that a difference in the overall dependent variable did not occur from baseline to 3 months (F[1, 104]=2.7, P=0.10), marginally occurred from baseline to 6 months (F[1, 104]=3.2, P=0.08), and was significant from 3 to 6 months (F[1, 104]=6.43, P=0.01).The overall significant interaction suggests varying responses in the dependent variables between RBAC and placebo over time, which is being driven by systolic blood pressure, as it decreased in the RBAC group, but increased in the placebo group. In addition, CD4+ manifested a non-significant increase from baseline to 3 months then decreased from 3 to 6 months in the RBAC group, whereas it decreased at 3 months followed by a slight increase at 6 months in the placebo group. Skin blood flow in response to nitric oxide improved non-significantly overall in both groups, but worsened from 3 to 6 months in the placebo group. Thus, RBAC treatment may contribute to modest short-term improvements in systolic blood pressure, endothelial function, and CD4+ cell count, which could help improve the overall health profile of HIV+ adults.Persons with HIV on ART suffer disproportionately from hypertension and endothelial dysfunction compared to the non-infected population, and conventional medical therapy does not alleviate these issues. RBAC is a safe, low-risk alternative that may help to improve the overall quality of life of these patients through modest improvements in these biomarkers plus CD4+ cell count." @default.
• W3041628293 created "2020-07-16" @default.
• W3041628293 creator A5000965474 @default.
• W3041628293 creator A5001368983 @default.
• W3041628293 creator A5002220312 @default.
• W3041628293 creator A5007626045 @default.
• W3041628293 creator A5007944239 @default.
• W3041628293 creator A5015290437 @default.
• W3041628293 creator A5015707245 @default.
• W3041628293 creator A5023045267 @default.
• W3041628293 creator A5023361088 @default.
• W3041628293 creator A5026016285 @default.
• W3041628293 creator A5026807986 @default.
• W3041628293 creator A5029742430 @default.
• W3041628293 creator A5037146513 @default.
• W3041628293 creator A5049295104 @default.
• W3041628293 creator A5049704908 @default.
• W3041628293 creator A5052617266 @default.
• W3041628293 creator A5062454453 @default.
• W3041628293 creator A5068288226 @default.
• W3041628293 creator A5071179920 @default.
• W3041628293 date "2020-04-13" @default.
• W3041628293 modified "2023-09-29" @default.
• W3041628293 title "Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV+ adults in a randomized, double-blind placebo-controlled trial." @default.
• W3041628293 cites W1492187418 @default.
• W3041628293 cites W1780490487 @default.
• W3041628293 cites W1964213751 @default.
• W3041628293 cites W1992192692 @default.
• W3041628293 cites W1998778897 @default.
• W3041628293 cites W2000894396 @default.
• W3041628293 cites W2002200453 @default.
• W3041628293 cites W2004405778 @default.
• W3041628293 cites W2008810901 @default.
• W3041628293 cites W2032586043 @default.
• W3041628293 cites W2053851300 @default.
• W3041628293 cites W2063197537 @default.
• W3041628293 cites W2096045342 @default.
• W3041628293 cites W2097512329 @default.
• W3041628293 cites W2099912006 @default.
• W3041628293 cites W2105359113 @default.
• W3041628293 cites W2110790984 @default.
• W3041628293 cites W2112972873 @default.
• W3041628293 cites W2117107523 @default.
• W3041628293 cites W2124726416 @default.
• W3041628293 cites W2135594909 @default.
• W3041628293 cites W2148314152 @default.
• W3041628293 cites W2152014155 @default.
• W3041628293 cites W2161795936 @default.
• W3041628293 cites W2162249283 @default.
• W3041628293 cites W2177014116 @default.
• W3041628293 cites W2531573051 @default.
• W3041628293 cites W2533303712 @default.
• W3041628293 cites W2563198170 @default.
• W3041628293 cites W2579809165 @default.
• W3041628293 cites W2599539620 @default.
• W3041628293 cites W2600005107 @default.
• W3041628293 cites W2608039664 @default.
• W3041628293 cites W2622539829 @default.
• W3041628293 cites W2679973791 @default.
• W3041628293 cites W2792808825 @default.
• W3041628293 cites W2799446522 @default.
• W3041628293 cites W2898443660 @default.
• W3041628293 cites W2899277506 @default.
• W3041628293 cites W4214514832 @default.
• W3041628293 cites W43845241 @default.
• W3041628293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7333168" @default.
• W3041628293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32637718" @default.
• W3041628293 hasPublicationYear "2020" @default.
• W3041628293 type Work @default.
• W3041628293 sameAs 3041628293 @default.
• W3041628293 citedByCount "1" @default.
• W3041628293 countsByYear W30416282932023 @default.
• W3041628293 crossrefType "journal-article" @default.
• W3041628293 hasAuthorship W3041628293A5000965474 @default.
• W3041628293 hasAuthorship W3041628293A5001368983 @default.
• W3041628293 hasAuthorship W3041628293A5002220312 @default.
• W3041628293 hasAuthorship W3041628293A5007626045 @default.
• W3041628293 hasAuthorship W3041628293A5007944239 @default.
• W3041628293 hasAuthorship W3041628293A5015290437 @default.
• W3041628293 hasAuthorship W3041628293A5015707245 @default.
• W3041628293 hasAuthorship W3041628293A5023045267 @default.
• W3041628293 hasAuthorship W3041628293A5023361088 @default.
• W3041628293 hasAuthorship W3041628293A5026016285 @default.
• W3041628293 hasAuthorship W3041628293A5026807986 @default.
• W3041628293 hasAuthorship W3041628293A5029742430 @default.
• W3041628293 hasAuthorship W3041628293A5037146513 @default.
• W3041628293 hasAuthorship W3041628293A5049295104 @default.
• W3041628293 hasAuthorship W3041628293A5049704908 @default.
• W3041628293 hasAuthorship W3041628293A5052617266 @default.
• W3041628293 hasAuthorship W3041628293A5062454453 @default.
• W3041628293 hasAuthorship W3041628293A5068288226 @default.
• W3041628293 hasAuthorship W3041628293A5071179920 @default.
• W3041628293 hasConcept C126322002 @default.
• W3041628293 hasConcept C142724271 @default.
• W3041628293 hasConcept C168563851 @default.
• W3041628293 hasConcept C203014093 @default.
• W3041628293 hasConcept C204787440 @default.
• W3041628293 hasConcept C27081682 @default.

• next